Stocks · Health care · Biological Products, (No Diagnostic Substances)

Pelthos Therapeutics Inc.

PTHS Clue Score29
United States Fiscal year ends December CIK 0001919246 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Todd C Davis
11 Jun 2026
Director
Buy
503
$28.73
$14.45K
Todd C Davis
11 Jun 2026
Director
Buy
35,445
$27.80
$985.53K
Knuettel Francis II
13 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
3,500
$0.97
$3.40K
Knuettel Francis II
12 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
1,700
$0.97
$1.65K
Richard Malamut
12 Sep 2024
Director
Buy indirect
10,400
$0.94
$9.82K
Knuettel Francis II
11 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
5,500
$0.94
$5.17K
Knuettel Francis II
10 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
6,500
$0.89
$5.79K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,206,057
History held since 23 Feb 2024